Life science

  Allied Market Research added new research on Multiplex Assay Market- Opportunity Analysis and Industry Forecast, 2022–2030. The Multiplex Assay market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing.  Some of the key players involved in the study are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd. Get Free Sample PDF of Multiplex Assay Market Report>>>  https://www.alliedmarketresearch.com/request-sample/1921 The global  multiplex assay market size  was valued at $1,940.49 million in 2020, and is projected to reach $4,366.32 million by 2030, registering a CAGR of 8.3% from 2021 t...

  Nimodipine Industry Report 2018 is a professional and in-depth survey on the current state of the Nimodipine industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nimodipine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Browse 174 tables and figures, 07 company profiles spread across 102 pages at  http://www.reportsnreports.com/reports/1371344-global-nimodipine-market-research-report-2018.html  . Global Nimodipine Industry 2018 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share a...

  Allied Market Research added new research on Artificial Intelligence For Drug Development and Discovery Market- Opportunity Analysis and Industry Forecast, 2022–2030. The Artificial Intelligence For Drug Development and Discovery market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing.  Some of the key players involved in the study are Alphabet Inc., Atomwise, Inc., Benevolent AI, Cloud Pharmaceutical, Deep Genomics, Exscientia, IBM Corporation, Insilico Medicine Inc., Microsoft Corporation, and Nvidia Corporation. Get Free Sample PDF of Artificial Intelligence For Drug Development and Discovery Market Report>>>  https://www.alliedmarketresearch.com/request-sample/5239 The artificial intelligence for drug discovery and development market size was valued at $0...

titled,  " GMP Testing Service Market  by Service Type (Product Validation Testing, Bioanalytical Services, Packaging and Shelf-Life Testing, Others), by End User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies): Global Opportunity Analysis and Industry Forecast, 2021-2031."  According to the report, the global GMP testing service industry generated  $1.3 billion  in 2021, and is expected to reach  $2.5 billion  by 2031, witnessing a CAGR of 6.7% from 2022 to 2031. Download Sample PDF at:  https://www.alliedmarketresearch.com/request-sample/17356   Drivers, Restraints and Opportunities Surge in usage of bioanalytical testing outsourcing services for drug development & validation and the development of biosimilars, combination products, and other medicines that raised the demand for specific testing procedures drive the growth of the global GMP testing service market. However, lack of stringent regulatory framewor...

Chimeric antigen receptor (CAR) T cell therapy treats certain cancers by converting T cells into cells that are more effective in fighting cancer.  CAR T-cell therapy  is a new targeted approach, which involves the genetic engineering of T cells to target specific receptors on cancer cells. The advantages of CAR T-cell therapy over conventional drugs include the destruction of cancer cells using the immune system and early recovery. In addition, CAR T-cell therapy survives in the body for a long time. It has the ability to recognize and target cancer cells even if the cancer returns. Therefore, CAR T-cell therapy is used to treat lymphoma, acute lymphocytic leukemia and multiple myeloma blood cancer. Due to its distinct advantages over conventional drugs, CAR T-cell therapy products are expected to witness high adoption rates, which will eventually lead to growth in the CAR T-cell therapy market size. ♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐎𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: ...

  Surge in respiratory diseases due to exposure to allergens, occupational exposure, and exposure to indoor and outdoor air pollution serves as a potential opportunity for the expansion of the global allergy diagnostics market. Based on region, North America held the largest share in 2021 and is projected to maintain its dominant share in terms of revenue in 2031. According to the report published by Allied Market Research, the global  Allergy Diagnostics Market  garnered $5.0 billion in 2021, and is estimated to generate $16.7 billion by 2031, manifesting a CAGR of 13.2% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for the sustainable growth and gaining competitive edge in the market. Download Report (390 Pages PDF with Insights, Cha...

  Allied Market Research recently published a report, titled,   " Single-use Bioprocessing Market  by Product (Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Filter Cartridges, Media Bags And Containers, Mixing Systems, Tubing Assemblies, Sampling Systems, Others), by Application (Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient-Specific Cell Therapies, Others), by Method (Filtration, Storage, Cell Culture, Mixing, Purification), by End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, Contract Research Organization & Manufacturers): Global Opportunity Analysis and Industry Forecast, 2020-2030."  According to the report, the global single-use bioprocessing industry generated   $7.0 billion   in 2020, and is estimated to reach   $38.8 billion   by 2030, witnessing a CAGR of 18.4% from 2021 to 2030. For Right Perspective, Download Sample P...

  Global   Ultrasound Devices Market   for pediatric radiology was valued at $661 million in 2015, and is poised to reach $1,112 million by 2022, registering an estimated of CAGR 7.6% during the forecast period. Ultrasound is a non-invasive diagnostic imaging method that uses high frequency sound waves to visualize images of the internal structures of the human body. Pediatric radiology is a subspecialty that involves radiologic manifestations of diseases that are prevalent among the pediatric population. The report analyzes the ultrasound devices market for pediatric radiology based on age group, portability, price, and geography. Download PDF Report Sample: https://www.alliedmarketresearch.com/request-sample/1901 Pediatric radiology is a subspecialty of radiology that deals with the imaging of fetuses, infants, children and adolescents. Special attention is paid to the training and development of pediatric radiologists in government and private organizations to meet the...